AEMD is not a revenue story yet. It is a clinical-stage Hemopurifier bet with FDA Breakthrough Device designations, an Australian oncology trial, a going-concern warning, reverse splits, warrant mechanics and a cash balance that makes every new data point matter.
References
Sources used in this report
SEC APISEC company tickers exchange dataset2026-05-14 · Ticker, issuer name, exchange and CIK confirmation.SEC APISEC submissions for Aethlon Medical2026-05-14 · Issuer identity, SIC, fiscal year end, filer category and recent filing sequence.SEC XBRL APISEC companyfacts for Aethlon Medical2026-05-14 · Tagged cash, assets, liabilities, losses, equity, operating cash flow and share metrics.SEC annual filingAethlon Medical fiscal 2025 Form 10-K2025-06-26 · Business description, no-revenue status, Hemopurifier overview, risk factors, going concern and annual financials.SEC quarterly filingAethlon Medical Q3 fiscal 2026 Form 10-Q2026-02-12 · Latest quarterly financials, cash, losses, going concern, clinical update and capital-structure disclosures.Company Form 8-K exhibitFiscal Q3 2026 results release2026-02-12 · Cohort 2, Nasdaq compliance, operating expenses, cash balance and management update.Company Form 8-K exhibitFiscal Q2 2026 results release2025-11-12 · Cohort 2 recruitment, Nasdaq compliance and operating-expense reduction context.Company Form 8-K exhibitFiscal Q4 2025 results release2025-06-26 · First three oncology-trial patients, fiscal 2025 financial summary and operating-expense reduction.Governance filingAethlon 2026 proxy statement2026-01-16 · Directors, officers, beneficial ownership, compensation and annual meeting proposals.SEC current reportAnnual meeting results Form 8-K2026-02-23 · Authorized-share increase, equity-plan amendment and warrant-related approvals.SEC current reportPre-funded warrant exercise Form 8-K2026-03-17 · Common shares outstanding and exercise of all previously outstanding pre-funded warrants.Clinical trial registryANZCTR trial ACTRN126240007325832026-05-14 · Australian oncology trial design, recruitment status, endpoints, target enrollment, sites and ethics approval.Clinical trial registryClinicalTrials.gov Aethlon Hemopurifier records2026-05-14 · Historical Hemopurifier trial statuses and enrollment context.Peer SEC annual filingCytoSorbents 2025 Form 10-K2026-03-30 · Peer context for extracorporeal blood purification, regulatory requirements and hospital workflow.